ZOSIMA INTON: Open Payments
NPI 1366626376 · VACAVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,861 in 87 payments from 14 companies in 2025. Trend: 2023 $1,144 · 2024 $1,337 · 2025 $1,861
Food & beverage: $1,861
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 32 | $638 |
| Novo Nordisk Inc | 19 | $404 |
| Gilead Sciences, Inc. | 12 | $255 |
| ABBVIE INC. | 7 | $157 |
| Merck Sharp & Dohme LLC | 3 | $142 |
| Exact Sciences Corporation | 2 | $54 |
| Indivior Inc. | 2 | $37 |
| SCILEX PHARMACEUTICALS INC. | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
Products named: DOVATO, Ozempic, APRETUDE, PIFELTRO, CABENUVA, QULIPTA, RUKOBIA, The Cologuard Plus Collection Kit.
Industry payments across CA — which companies pay providers there.
